These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6465702)

  • 41. Vitamin C, use or abuse?
    Dettman G
    Australas Nurses J; 1982 Nov; 11(10):8-12. PubMed ID: 6925943
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis.
    Sirover WD; Liu Y; Logan A; Hunter K; Benz RL; Prasad D; Avila J; Venkatchalam T; Weisberg LS; Handelman GJ
    J Ren Nutr; 2015 May; 25(3):292-300. PubMed ID: 25455040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors contributing to oxalate deposits in the myocardia of hemodialysis patients.
    Ono K; Kikawa K
    ASAIO Trans; 1989; 35(3):595-7. PubMed ID: 2597543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary oxalosis as a complication of parenteral alimentation in acute renal failure.
    Friedman AL; Chesney RW; Gilbert EF; Gilchrist KW; Latorraca R; Segar WE
    Am J Nephrol; 1983; 3(5):248-52. PubMed ID: 6416068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of vitamin C intake on whole blood plasma, leucocyte and urine ascorbic acid and urine oxalic acid levels.
    Erden F; Hacisalihoğlu A; Koçer Z; Simşek B; Nebioğlu S
    Acta Vitaminol Enzymol; 1985; 7(1-2):123-30. PubMed ID: 4036755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of ascorbic acid in suboptimal responsive anemic hemodialysis patients receiving erythropoietin: a meta-analysis.
    Einerson B; Chaiyakunapruk N; Kitiyakara C; Maphanta S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S134-46. PubMed ID: 21721439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antioxidant treatment in dialysis patients- importance of ferritin.
    Ersoy A
    Nephrol Dial Transplant; 2006 Jul; 21(7):2035-6. PubMed ID: 16504978
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro synthesis of oxalic acid has no relevant influence on plasma oxalic acid levels in haemodialysis patients.
    Balcke P; Schmidt P; Zazgornik J; Haubenstock A; Kopsa H
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):261-3. PubMed ID: 6726124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [L-ascorbic acid and long-term dialysis program].
    Mydlík M; Derzsiová K; Takác M
    Cas Lek Cesk; 1976 Jan; 115(4):115-9. PubMed ID: 1253213
    [No Abstract]   [Full Text] [Related]  

  • 50. Oxalic acid as an extractant of ascorbic acid from plant materials and its effect on the stability of ascorbic acid.
    BABBAR IJ; AHMAD B
    Ann Biochem Exp Med; 1949; 9(2):103-6. PubMed ID: 18138230
    [No Abstract]   [Full Text] [Related]  

  • 51. Oxalate depuration during biofiltration with AN69 and in conventional hemodialysis in chronic renal failure (CRF) patients.
    Chimienti S; Mele G; Perrone F; Muscogiuri P; Cristofano C
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():73-4. PubMed ID: 3557678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case report 599: Secondary oxalosis complicating chronic renal failure (oxalate gout).
    Coral A; van Holsbeeck M; Hegg C
    Skeletal Radiol; 1990; 19(2):147-9. PubMed ID: 2321046
    [No Abstract]   [Full Text] [Related]  

  • 53. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of severe hyperoxalaemia in Crohn's disease-related renal failure on maintenance haemodialysis: successful management with pyridoxine.
    Marangella M; Vitale C; Petrarulo M; Cosseddu D; Gallo L; Linari F
    Nephrol Dial Transplant; 1992; 7(9):960-4. PubMed ID: 1328946
    [No Abstract]   [Full Text] [Related]  

  • 55. Vitamin C and iron overload in a chronic hemodialysis patient.
    Haubenstock A; Balcke P; Schmidt P; Pils P; Schröcksnadel W; Zyman H
    Clin Nephrol; 1985 Jan; 23(1):51-2. PubMed ID: 3978883
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
    Tomson CR; Channon SM; Parkinson IS; Owen JP; Ward MK; Simpson JM; Laker MF
    Nephrol Dial Transplant; 1988; 3(3):295-9. PubMed ID: 3140104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogenesis of acquired renal cysts in hemodialysis patients. The role of oxalate crystal deposition in renal tubules.
    Ono K; Yasukohchi A; Kikawa K
    ASAIO Trans; 1987; 33(3):245-9. PubMed ID: 3314920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin C.
    Lykkesfeldt J; Michels AJ; Frei B
    Adv Nutr; 2014 Jan; 5(1):16-8. PubMed ID: 24425716
    [No Abstract]   [Full Text] [Related]  

  • 59. Re-evaluation of ascorbic acid deficiency in hemodialysed patients.
    Papastephanidis C; Agroyannis B; Tzanatos-Exarchou H; Orthopoulos B; Koutsicos D; Frangos-Plemenos M; Kallitsis M; Yatzidis H
    Int J Artif Organs; 1987 May; 10(3):163-5. PubMed ID: 3610366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
    Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
    Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.